Dr. Mark A. Kazewych, M.D.
Orthopedic Surgery (Orthopaedic Surgery Physician)
- Medicare participating
At a glance
- Medical school
- Northeastern Ohio University College of Medicine (1995)
- Years since graduation
- 31
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 298
Licensed in Texas since 2002, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1995Medical school: Northeastern Ohio University College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Orthopaedic Surgery Physician primary
TX license L5404 (first issued 2002; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Baylor Scott and White Orthopedic and Spine Hospi Arlington, TX
Medical groups
- Healthtexas Provider Network (2,697 clinicians)
- Orthotx PLLC (85 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 298
- Services billed
- 1,383
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 292 | 54 |
| Established patient office or other outpatient visit, 20-29 minutes | 213 | 156 |
| X-ray of knee, 4 or more views | 203 | 121 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 187 | 45 |
| Established patient office or other outpatient visit, 30-39 minutes | 173 | 140 |
| Aspiration and/or injection of fluid from large joint | 128 | 99 |
| X-ray of shoulder, minimum of 2 views | 111 | 84 |
| X-ray of hip, 2-3 views | 99 | 61 |
| New patient office or other outpatient visit, 30-44 minutes | 45 | 45 |
| Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | 36 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Meloxicam Other prescribers in Arlington, TX | 167 |
| Celecoxib Other prescribers in Arlington, TX | 121 |
| Oxycodone-Acetaminophen (oxycodone hcl/acetaminophen) Other prescribers in Arlington, TX | 82 |
| Amoxicillin Other prescribers in Arlington, TX | 49 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Arlington, TX | 40 |
| Ondansetron Hcl Other prescribers in Arlington, TX | 35 |
| Gabapentin Other prescribers in Arlington, TX | 12 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 10 companies reported 16 payments worth $1,056 in total to this clinician.
| Stryker Corporation | $315 |
|---|---|
| Smith+nephew, Inc. | $230 |
| Vericel Corporation | $194 |
| Zimmer Biomet Holdings, Inc. | $71.51 |
| Carbofix Orthopedics Inc | $63.87 |
| Pylant Medical | $49.35 |
| Highridge Medical LLC | $40.89 |
| Ebi, LLC | $40.89 |
| Food and Beverage | $1,056 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $12,901 in research payments for these studies, mostly to the institutions running them.
- A Post Approval Multicenter Open-label Randomized Controlled Trial of Agili-C vs. Surgical Standard of Care (SSOC) for the Treatment of Joint Surface Lesions of the Knee
Smith+nephew, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.